IDEXX Laboratories (HAM:IX1) Other Long Term Assets: €446 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:IX1 IDEXX Laboratories Inc HAM:IX1
96 GF Score
Price €489.00
GF Value €556.72
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Other Long Term Assets?

IDEXX Laboratories HAM:IX1 -2.82% 96 Other Long Term Assets is €446 Mil as of Jun. 2026. GuruFocus rates HAM:IX1 with a GF Score™ of 96/100 and a GF Value™ of €556.72 (Modestly Undervalued).

IDEXX Laboratories's other long-term assets for the quarter that ended in Jun. 2026 was €446 Mil.

IDEXX Laboratories's quarterly other long-term assets increased from Dec. 2025 (€413 Mil) to Mar. 2026 (€432 Mil) and increased from Mar. 2026 (€432 Mil) to Jun. 2026 (€446 Mil).

IDEXX Laboratories's annual other long-term assets increased from Dec. 2023 (€404 Mil) to Dec. 2024 (€468 Mil) but then declined from Dec. 2024 (€468 Mil) to Dec. 2025 (€413 Mil).

IDEXX Laboratories Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Other Long Term Assets Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 275.95 341.94 403.79 467.76 413.33

IDEXX Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 452.98 387.24 413.33 431.81 445.97
HAM:IX1
96GF Score
IDEXX Laboratories Inc HAM:IX1
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of €446 Mil mean?
IDEXX Laboratories (HAM:IX1) has a Other Long Term Assets of €446 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Other Long Term Assets too high?
IDEXX Laboratories' current Other Long Term Assets is €446 Mil. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Other Long Term Assets compare to A and NTRA?
IDEXX Laboratories' Other Long Term Assets of €446 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Diagnostics & Research company?
A good Other Long Term Assets depends on the Medical Diagnostics & Research industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Other Long Term Assets is €446 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (HAM:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €556.72, compared to a current price of €489.00 — trading 12.2% below its estimated fair value. The current Other Long Term Assets is €446 Mil. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For IDEXX Laboratories (HAM:IX1), the current Other Long Term Assets is €446 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (HAM:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €489.00 is trading 12.2% below its estimated GF Value™ of €556.72. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for HAM:IX1:

  • Other Long Term Assets: €446 Mil
  • GF Value™: €556.72 vs. price of €489.00 (12.2% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the HAM:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for HAM:IX1

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€489.00
Price
€556.72
GF Value